SEC 13F Intelligence

Endurance Wealth Management, Inc. / ABBV

Endurance Wealth Management, Inc.’s Abbvie Inc Position

Does Endurance Wealth Management, Inc. own Abbvie Inc (ABBV)? Yes102.1K shares worth $14M (+1.88% of its 13F portfolio) as of Q2 2023, up from 101.3K shares the prior filed quarter.

Position Value
$14M
Q2 2023
Shares
102.1K
% of Portfolio
+1.88%
Quarters Held
18
currently held

Position History ABBV

Reported value by quarter
Q1 ’19: $7MQ1 ’19Q2 ’19: $6MQ3 ’19: $6MQ4 ’19: $8MQ4 ’19Q1 ’20: $7MQ2 ’20: $10MQ3 ’20: $10MQ3 ’20Q4 ’20: $12MQ1 ’21: $12MQ2 ’21: $13MQ2 ’21Q3 ’21: $12MQ4 ’21: $14MQ1 ’22: $16MQ1 ’22Q2 ’22: $15MQ3 ’22: $13MQ4 ’22: $16MQ4 ’22Q1 ’23: $16MQ2 ’23: $14Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 2023102.1K$14M+1.88%
Q1 2023101.3K$16M+2.27%
Q4 202299.4K$16M+2.42%
Q3 202298.8K$13M+2.19%
Q2 202298.7K$15M+2.30%
Q1 202299.7K$16M+2.09%
Q4 2021105.7K$14M+1.54%
Q3 2021112.9K$12M+1.35%
Q2 2021113.7K$13M+1.42%
Q1 2021113.0K$12M+1.44%
Q4 2020109.6K$12M+1.48%
Q3 2020109.0K$10M+1.41%
Q2 2020102.0K$10M+1.64%
Q1 202097.4K$7M+1.43%
Q4 201994.2K$8M+1.28%
Q3 201984.9K$6M+1.07%
Q2 201986.9K$6M+0.99%
Q1 201986.0K$7M+1.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurance Wealth Management, Inc.’s full portfolio or all institutional holders of ABBV.